MedTrace Logo

Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?

NCT02040350 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-01-20

No results posted yet for this study

Summary

To evaluate the effectiveness of Pralidoxime, a drug used for treatment of pesticide poisoning (Organophosphorous poisonings)

Conditions

  • Deaths

Interventions

DRUG

Pralidoxime

Pralidoxime was compared to placebo to study the effects of the drug on mortatlity

Sponsors & Collaborators

  • Sheri Kashmir Institute of Medical Sciences

    lead OTHER

Principal Investigators

  • Showkat Gurcoo, MD · SKIMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
14 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-08-31
Completion
2013-11-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02040350 on ClinicalTrials.gov